Enhancer Detail

Comprehensive information about experimentally validated enhancers

About Enhancer
Enhancer ID: E_02346
Species: Homo sapiens
Position : chr6:12902957-12904957
Year: 2015
Title: Myocardial Infarction-Associated SNP at 6p24 Interferes With MEF2 Binding and Associates With PHACTR1 Expression Levels in Human Coronary Arteries.
Genome Build: hg19
Enhancer Type: Enhancer
Condition: Disease
Disease Name: coronary artery disease
PMID:  25838425
Tissue: coronary artery
Tissue Ontology ID: UBERON:0001621
Cell Source: HUVEC and hESC-derived endothelial cells
Cell Type: endothelial cell
Cell Ontology ID: CL:0000115
Experiment Type: TF binding assay; Allele-specific cis-regulatory assay; Functional genome-editing assay; Endogenous enhancer perturbation; Disease-variant functional analysis
High Throughput Method: Genetic fine-mapping; coronary-artery eQTL analysis; Roadmap Epigenomics integration; eQTL analysis; GWAS
Low Throughput Method: EMSA/supershift; CRISPR/Cas9 deletion of the MEF2-binding site; RT-qPCR; CRISPR-Cas9 endogenous deletion/editing
About Target Gene
Target gene : PHACTR1
About TF
TF name : MEF2A
About Regulatory State
Regulatory State : Active
Upstream Pathway Annotation of TF
GeneName Pathway Name Source Gene Number
MEF2A CDO in myogenesis reactome 29
MEF2A ERK/MAPK targets reactome 17
MEF2A Signaling mediated by p38-alpha and p38-beta pid 35
MEF2A TGF_beta_Receptor netpath 220
MEF2A Hs_p38_MAPK_Signaling_Pathway_WP400_72084 wikipathways 28
Enhancer Associated Network
Overlapping Enhancers (hg19) 3 found
Enhancer ID Position Tissue Cell Disease
E_01181 chr6:12902957-12904957 aorta endothelial cell vascular disease susceptibility
E_01287 chr6:12902957-12904957 blood vessel endothelial cell vascular disease susceptibility
E_01299 chr6:12903457-12904457 red nucleus endothelial cell pleiotropic vascular-disease susceptibility locus
Expression of Target Genes for the Enhancer